↓ Skip to main content

Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study

Overview of attention for article published in Neurology, October 2004
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
7 tweeters
patent
5 patents
facebook
4 Facebook pages

Citations

dimensions_citation
163 Dimensions

Readers on

mendeley
173 Mendeley
connotea
1 Connotea
Title
Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study
Published in
Neurology, October 2004
DOI 10.1212/01.wnl.0000140288.48796.8e
Pubmed ID
Authors

C. B. Carroll, P. G. Bain, L. Teare, X. Liu, C. Joint, C. Wroath, S. G. Parkin, P. Fox, D. Wright, J. Hobart, J. P. Zajicek

Abstract

The long-term treatment of Parkinson disease (PD) may be complicated by the development of levodopa-induced dyskinesia. Clinical and animal model data support the view that modulation of cannabinoid function may exert an antidyskinetic effect. The authors conducted a randomized, double-blind, placebo-controlled crossover trial to examine the hypothesis that cannabis may have a beneficial effect on dyskinesia in PD.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 1%
United States 2 1%
Spain 1 <1%
Unknown 168 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 14%
Student > Bachelor 22 13%
Researcher 20 12%
Other 19 11%
Student > Doctoral Student 14 8%
Other 36 21%
Unknown 38 22%
Readers by discipline Count As %
Medicine and Dentistry 48 28%
Neuroscience 17 10%
Agricultural and Biological Sciences 17 10%
Psychology 14 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Other 20 12%
Unknown 47 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2019.
All research outputs
#659,526
of 15,074,180 outputs
Outputs from Neurology
#1,212
of 15,171 outputs
Outputs of similar age
#4,511
of 126,329 outputs
Outputs of similar age from Neurology
#7
of 87 outputs
Altmetric has tracked 15,074,180 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,171 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,329 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.